Skip to content

Impact of telemedicine medical guidance on the continuation and satisfaction rates of the Etonogestrel releasing implant inserted after childbirth

Impact of telemedicine medical guidance on the continuation and satisfaction rates of the Etonogestrel releasing implant inserted in the immediate postpartum period

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9nmm7sz
Enrollment
Unknown
Registered
2025-02-25
Start date
2024-10-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception, contraceptive counseling, Routine postpartum follow-up, Postpartum

Interventions

This is an open-label, randomized, controlled, parallel superiority clinical trial. Only the statistician will be blinded during data analysis. Postpartum women who opt for the use of the Etonogestrel
V03.175.500
H02.403.840

Sponsors

Faculdade de Odontologia de Bauru da Universidade de São Paulo
Lead Sponsor
Faculdade de Odontologia de Bauru da Universidade de São Paulo
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Postpartum women who have given birth at the Santa Isabel Maternity Hospital; aged between 18 and 45 years; who express a desire to use the Etonogestrel implant after contraceptive instructions; who regularly have access to cell phones with the ability to receive video messages

Exclusion criteria

Exclusion criteria: Patients who do not have a mobile phone with access to the internet and the free WhatsApp messaging application; women with clinical conditions that hinder understanding of the video (addiction to the use of alcohol and/or illicit drugs, vision or hearing difficulties, psychiatric illnesses without adequate clinical treatment); homeless women

Design outcomes

Primary

MeasureTime frame
Higher satisfaction rates are expected after 1 year of use of the Etonogestrel Implant in the group that received ongoing guidance through educational videos and telemedicine, assessed by satisfaction assessment questionnaires

Secondary

MeasureTime frame
Higher one-year continuation rates of Etonogestrel Implant use are expected in the group that received ongoing counseling through educational videos and telemedicine, evaluating the number of patients who maintain use of the method in 1 year

Countries

Brazil

Contacts

Public ContactMariane Nadai

Faculdade de Odontologia de Bauru

mariane.nunes@usp.br+551432358386

Outcome results

None listed

Source: REBEC (via WHO ICTRP)